CNR Institutional Research Information System

DE FRANCISCIS, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 138
NA - Nord America 29
EU - Europa 16
Totale 183
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 122
US - Stati Uniti d'America 29
KR - Corea 16
IT - Italia 14
ES - Italia 1
NL - Olanda 1
Totale 183
Salva come PNG Salva come JPEG
Città #
Singapore 88
Seoul 16
Santa Clara 8
Naples 4
Sala Baganza 2
Amsterdam 1
Ashburn 1
Casoria 1
Forest City 1
Fort Worth 1
Granadilla de Abona 1
Totale 124
Salva come PNG Salva come JPEG
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 13
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 11
Selection of a nuclease‐resistant rna aptamer targeting cd19 9
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 7
Affinity immobilization of aptamers on graphene oxide for biosensor applications 5
A trans-disciplinary approach to cancer research 5
Aptamers as innovative diagnostic and therapeutic agents in the central nervous system 4
Combined targeting of glioblastoma stem-like cells by neutralizing RNA-bio-drugs for STAT3 4
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor 3
Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases. 3
A Trojan horse for human immunodeficiency virus 3
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 3
Aptamers as innovative diagnostic and therapeutic agents in the central nervous system. 3
Shp2 in PC12 cells: NGF versus EGF 3
Aptamer-mediated targeted delivery of therapeutics: An update 3
Engineering Aptamers for Biomedical Applications: Part II 3
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 3
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 3
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 3
Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK 3
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 3
Aptamer chimeras for therapeutic delivery: The challenging perspectives 3
Shp2 in PC12 cells: NGF versus EGF 2
Noncoding RNAs in Cancer Medicine. 2
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death. 2
cleic acids in human glioma treatment: innovative approaches and recent results 2
Cell-Specific Aptamers for Targeted Therapies 2
Identification of an interfering ligand aptamer for EphB2/3 receptors 2
Coupling aptamers to short interfering RNAs as therapeutics 2
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 2
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 2
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 2
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 2
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 2
Nucleic acid aptamers for in vivo molecular imaging 2
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 2
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 2
Challenging cancer targets for aptamer delivery. 2
Aptamers as Innovative Diagnostic and Therapeutic Agents in the Central Nervous System 2
Differential SELEX in human glioma cell lines. 2
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 2
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 2
Developing aptamers by cell-based SELEX 2
ANALYSIS AND SEQUENCING OF THE GENOMIC DNA REGION SPANNING THE HUMAN DBL PROTOONCOGENE 2
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells 2
Nucleic acids delivering nucleic acids 2
Aptamers in Bordeaux, 24-25 June 2016 2
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 2
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site. 2
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 2
Aptamer-miRNA conjugates for cancer cell-targeted delivery 2
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 2
RET/PTC activation in human thyroid carcinomas 2
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing 2
Targeting cancer cells with nucleic acid aptamers 2
Cell-specific aptamers for targeted therapies. 2
A Theranostic "SMART" Aptamer for Targeted Therapy of Prostate Cancer. 1
Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells 1
Arresting the colonial destiny of metastatic seeds with DNA aptamers. 1
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 1
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 1
Thyrotropin stimulates transcription from the ferritin heavy chain promoter 1
Nucleic acid aptamers in cancer medicine. 1
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 1
The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret 1
Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B 1
Use of yeast artificial chromosomes to study the genomic organization of human dbl proto-oncogene. 1
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells 1
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 1
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 1
Nucleic Acid-Based Aptamers As Promising Therapeutics In Neoplastic Diseases 1
New insight into clinical development of nucleic acid aptamers. 1
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 1
Nucleic acid aptamers against protein kinases. 1
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 1
Recent advance in biosensors for microRNAs detection in cancer 1
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor. 1
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten Murine Sarcoma Virus 1
Comparison of Different Strategies to Select Aptamers Against a Transmembrane Protein Target 1
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site 1
Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation 1
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 1
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1
TSH regulation of ferritin H chain messenger RNA levels in the rat thyroids 1
5'-End ret splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. 1
Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development . 1
Totale 198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.567
article - articoli 1.419
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 109
Totale 3.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 1 0 23 11
2024/2025163 9 4 101 48 1 0 0 0 0 0 0 0
Totale 198